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Activation of visceral nociceptors by inflammatory mediators contributes to visceral hypersensitivity and abdominal pain associated
with many gastrointestinal disorders. Purine and pyrimidine nucleotides (e.g., ATP and UTP) are strongly implicated in this process
following their release from epithelial cells during mechanical stimulation of the gut, and from immune cells during inflammation.
Actions of ATP are mediated through both ionotropic P2X receptors and metabotropic P2Y receptors. P2X receptor activation causes
excitationof visceral afferents; however, the impact of P2Y receptor activationonvisceral afferents innervating the gut is unclear.Herewe
investigate the effects of stimulating P2Y receptors in isolated mouse colonic sensory neurons, and visceral nociceptor fibers in mouse
andhumannerve-gutpreparations.Additionally,we investigate the roleofNav1.9 inmediatingmurine responses.TheapplicationofUTP
(P2Y2 andP2Y4 agonist) sensitized colonic sensory neurons by increasing actionpotential firing to current injection anddepolarizing the
membrane potential. The application of ADP (P2Y1 , P2Y12 , and P2Y13 agonist) also increased action potential firing, an effect blocked by
the selective P2Y1 receptor antagonist MRS2500. UTP or ADP stimulated afferents, includingmouse and human visceral nociceptors, in
nerve-gut preparations. P2Y1 and P2Y2 transcripts were detected in 80% and 56% of retrogradely labeled colonic neurons, respectively.
Nav1.9 transcripts colocalized in 86%of P2Y1-positive and 100%of P2Y2-positive colonic neurons, consistent with reduced afferent fiber
responses to UTP and ADP in Nav1.9
/ mice. These data demonstrate that P2Y receptor activation stimulates mouse and human
visceral nociceptors, highlighting P2Y-dependent mechanisms in the generation of visceral pain during gastrointestinal disease.
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Introduction
Visceral pain is a principal symptom of many gastrointestinal
disorders and is strongly associated with inflammation and me-
chanical stimulation of the gut (Knowles and Aziz, 2009). One
endogenous mediator of bowel discomfort and pain is ATP,
which is released from the mucosal epithelium during distension
(Burnstock, 2009), particularly during colitis (Shinoda et al.,
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Significance Statement
Chronic visceral pain is a debilitating symptom ofmany gastrointestinal disorders. The activation of pain-sensing nerves located
in the bowel wall and their sensitization to physiological stimuli, including bowelmovements, underpins the development of such
pain, and is associated with mediators released during disease. This work addresses the unstudied role of purine and pyrimidine
nucleotides in modulating colonic nociceptors via P2Y receptors using a combination of electrophysiological recordings from
human ex vivo samples and adetailed functional study in themouse. This is the first report to identify colonic purinergic signaling
as a function of P2Y receptor activation, in addition to established P2X receptor activity, and the results contribute to our
understanding of the development of visceral pain during gastrointestinal disease.
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2009). Both ionotropic P2X and metabotropic P2Y receptors are
activated by extracellular ATP. Of the seven reported P2X recep-
tors (P2X1–P2X7), P2X2 and P2X3 receptor subunits are widely
expressed in gut-projecting sensory neurons and contribute to
the transduction of nociceptive visceral signals in the bowel (Shi-
noda et al., 2009). By contrast, the role of P2Y receptors in the
processing of visceral pain has not been studied in detail. Eight
members of the P2Y receptor family (P2Y1, P2Y2, P2Y4, P2Y6,
and P2Y11–14) have been identified responding to endogenous
purine and pyrimidine nucleotides (ATP and UTP; Lazarowski
and Harden, 1999; Lazarowski and Boucher, 2001; Gerevich and
Illes, 2004). Each P2Y receptor binds a heterotrimeric G-protein,
the activation of which results in intracellular signaling casca-
des, including the release of intracellular Ca2 stores (Sanada et
al., 2002) capable of sensitizing sensory neurons (Yousuf et al.,
2011). P2Y1, P2Y2, P2Y4, and P2Y6 receptors are Gq/11 coupled
and excitatory in function. P2Y12-14 receptors are Gi coupled and
are inhibitory in function. No rodent ortholog of P2Y11 exists
(von Ku¨gelgen, 2006). P2Y receptor agonists cause pain in hu-
man blister-base preparations, directly activate mouse cutaneous
afferents, and can regulate their sensitivity to mechanical and
thermal stimuli (Bleehen and Keele, 1977; Tominaga et al., 2001;
Stucky et al., 2004).
Multiple ion channels act as downstream effectors for P2Y
receptor-mediated changes in neuronal excitability. For example,
P2Y1 receptor activation potentiates transient receptor potential
vanilloid 1 currents, leading to hyperalgesia in rodents (Tomi-
naga et al., 2001). M-currents (mediated by KV7) that contribute
to restingmembrane potentials are alsomodulated by P2Y recep-
tors (Zaika et al., 2007; Yousuf et al., 2011). Recently, we have
shown that voltage-gated sodium channel subtype Nav1.9 is a
major regulator of visceral afferent excitability to noxious me-
chanical and inflammation stimuli, including ATP and media-
tors derived from patients with inflammatory bowel disease
(IBD; Hockley et al., 2014). Under certain conditions, we have
shown that Nav1.9 currents can be enhanced by ATP (Baker,
2005), suggesting that P2Y receptor activation can enhance
Nav1.9 currents, stimulating visceral afferents. This is supported
by in vivo observations that UTP-induced paw hypersensitivity is
lost in Nav1.9
/ mice (Amaya et al., 2006). It is therefore of
considerable interest to understandwhether P2Y receptor activa-
tion stimulates visceral nociceptors and whether Nav1.9 contrib-
utes to these effects.
The goals of the study were (1) to determine the effects of P2Y
receptor activation on the excitability of colonic sensory neurons,
(2) to investigate P2Y receptor activation ofmouse afferent fibers
including visceral nociceptors, (3) to demonstrate the translation
of these effects frommouse to human, and (4) to understand the
role for Nav1.9 as a common transducer of visceral afferent excit-
ability to P2Y receptor signaling.
Materials andMethods
Experiments were performed using male C57BL/6 mice (10–12 weeks of
age) and Nav1.9 knock-out (Nav1.9
/) or wild-type (Nav1.9
/) mice
bred on a C57BL/6 background (for original characterization, see Ost-
man et al., 2008). Mice were housed in a 12 h light/dark cycle with ad
libitum access to food and water. All protocols were performed in accor-
dance with the UK Animal (Scientific Procedures) Act 1986. Human
tissue was collected and used with approval of the East London and The
City HA Local Research Ethics Committee (NREC 10/H0703/71).
Retrograde labeling of colonic sensory neurons.Malemice were anesthe-
tized with 1.5% isoflurane, and a midline 1.5 cm laparotomy was per-
formed. Five injections of 0.2l Fast Blue (FB: 2% in saline; Polysciences
GmbH) per site, were made into the wall of the distal colon using a fine
pulled-glass needle andmicroinfusionpump (0.4l/min). The abdomen
was flushed with saline solution to remove any excess FB, and the peri-
toneal muscle layer was sutured and the skin secured with Michel clips.
Postoperative analgesia (buprenorphine 0.05–0.1 mg/kg daily) and care
(monitoring body weight and soft diet) was provided.
Primary culture of mouse dorsal root ganglia neurons. Three to five days
after surgery, mice were humanely killed by concussion of the brain and
cervical dislocation of the neck, and thoracolumbar (TL; T10–L1) dorsal
root ganglia (DRGs) were harvested for electrophysiological whole-cell
recordings. Dissected ganglia were washed in Dulbecco’s PBS and then
incubated at 37°C (in 5% CO2) in Lebovitz L-15 Glutamax (Invitrogen)
media containing 1 mg/ml collagenase type 1A (Sigma-Aldrich) and 6
mg/ml bovine serum albumin (BSA; Sigma-Aldrich) for 15min. Ganglia
were incubated in L-15 media containing 1 mg/ml trypsin (Sigma-
Aldrich) and 6mg/ml BSA for 30min. The ganglia were gently triturated
using fire-polished pipettes and collected by brief centrifugation at 500
g. The supernatant (containing dissociated cells) was collected, and gen-
tle trituration and centrifugation of ganglia were repeated five times.
Cells were pelleted and resuspended in Lebovitz L-15 Glutamax media
containing 2%penicillin/streptomycin, 24mMNaHCO3, 38mM glucose,
and 10% fetal bovine serum. Cells were plated onto poly-D-lysine/
laminin-coated coverslips (BDBiosciences) and incubated at 37°C in 5%
CO2. All electrophysiological recordings were performed within 24 h of
plating.
Patch-clamp electrophysiology.Coverslips were transferred to a record-
ing chamber continually perfused with the following extracellular solu-
tion (in mM): 140 NaCl, 4 KCl, 1.8 CaCl2, 1 MgCl2, 10 HEPES, and 5
glucose, pH adjusted to 7.4 withNaOH at room temperature.Whole-cell
patch-clamp recordings were made using a Molecular Devices Axopatch
200B amplifier, digitized at 10 kHz (Digidata 1440), and controlled by
pClamp 9 software. Glass borosilicate pipettes were used with a typical
pipette resistance of 2–3 M, resulting in series resistance of 10 M.
Pipettes were filled with the following intracellular solution (inmM): 140
KCl, 1.6MgCl2, 2.5MgATP, 0.5NaGTP, 2 EGTA, and 10HEPES, andpH
adjusted to 7.3. After the formation of whole-cell recordings, cells were
clamped at60mV, andmembrane excitability was tested by increasing
current injections at 50 pA increments to 650 pA, with each lasting 500
ms. Only Fast-Blue-positive colonic sensory neurons with resting mem-
brane potentials more negative than 40 mV were studied. The total
number of action potentials elicited by current injections was quantified
before and after the application of nucleotide for 2min by rapid exchange
of the recording chamber perfusate. The selective P2Y1 receptor antago-
nistMRS2500 was applied for 2min before and during the application of
ADP (Hechler et al., 2006).
Mouse colonic splanchnic afferent preparations.Mice of either sex were
humanely killed by a rising concentration of CO2, and the distal colon
with associated lumbar splanchnic nerves (LSNs) was removed. Tissues
were superfused (7ml/min; 32–34°C)with carbogenatedKrebs buffer (in
mM: 124 NaCl, 4.8 KCl, 1.3 NaH2PO4, 2.5 CaCl2, 1.2 MgSO4.7H2O, 11.1
glucose, and 25 NaHCO3) supplemented with nifedipine (10 M) and
atropine (10 M) to block smooth muscle contraction, and indometha-
cin (3 M) to block endogenous prostanoid production. In whole-nerve
studies, the colon was cannulated and luminally perfused (100 l/min)
with the same supplemented Krebs buffer. For teased nerve fiber studies,
the colon was opened along the antimesenteric border and pinned with
the flat mucosal side up.
Humanmesenteric afferent preparations.Resected humanbowel tissues
were obtained after full written consent from 28 patients undergoing
surgery at Barts Health NHS Trust, London. All applicable patients were
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invited to participate in the study, and pharmacological treatment regi-
mens were not accounted for in patient selection. Descending colon,
appendix, and ileumwere obtained from patients undergoing colectomy
as part of their normal surgical treatment for bowel cancer, inflammatory
bowel disease, stricture, trauma, and slow-transit constipation (Table 1).
For cancer resections, only tissue that was not required for histopatho-
logical assessment (e.g., tissue taken away from the tumor or resection
margins or lymphatic drainage field) was used. Tissues from inflamma-
tory bowel disease resections were derived from both chronically in-
flamed and resolving regions of bowel; however, all patients possessed
active disease that was unresponsive to medical treatment. Once re-
moved, tissueswere immediately placed in coldKrebs buffer before sharp
dissection of full-thickness colonic wall (4 cm square with the mesen-
teric fan down the center), and, depending on length, appendix speci-
mens were split in two or used in their entirety. Tissue was superfused
with Krebs buffer (7 ml/min; 32–34°C) supplemented with 10 M nifed-
ipine and 10 M atropine. Under a dissection microscope, the neurovas-
cular bundles in the associated mesentery were blunt dissected, and
mesenteric nerveswere identified and subsequently cleared of connective
tissue (Peiris et al., 2011).
Electrophysiological recordings of mouse and human visceral nerves.
Multiunit activity or single-unit activity (from teased fibers) from whole
LSNs (rostral to the inferior mesenteric ganglia) of mouse, or frommes-
enteric nerves of human bowel tissues, was recorded using borosilicate
glass suction electrodes. Signals were amplified, bandpass filtered (gain
5K; 100–1300 Hz; Neurolog, Digitimer Ltd), digitally filtered for 50 Hz
noise (Humbug, Quest Scientific), and digitized at 20 kHz (micro1401,
Cambridge Electronic Design). In whole-nerve multiunit recordings, a
threshold of twice the background noise (typically, 100 V) was used to
determine action potential firing counts and the signal displayed on a PC
using Spike 2 software. In mouse flat sheet preparations, receptive fields
were characterized by von Frey hair (VFH) probing (1 g; applied three
times for a period of 3 s), circumferential stretch (5 g; applied for 1 min),
andmucosal strokingwith a light von Frey hair (0.16 g; applied 10 times).
A claw attached to the tissue adjacent to the receptive field was used to
apply circumferential stretch by addition of a 5 g weight in a cantilever
system. Comparable methodology was used to characterize receptive
fields from human mesenteric nerve recordings. This included von Frey
hair probing (2 g; applied 3 times for a period of 3 s), circumferential and
longitudinal stretch (curved forceps were used to apply stretch across the
receptive field repeated three times; 5 min interval), and mucosal strok-
ing with a rod (three times; 5 min interval). Afferent fibers were charac-
terized into the following four previously established classes based on
these responses: mesenteric (those responding to focal compression of
the mesentery); serosal (those responding to focal compression of the
colon wall, but not mucosal stroke or stretch); muscular (those respond-
ing to stretch, but not fine mucosal stroking); and mucosal (those re-
sponding to mucosal stroking; Brierley et al., 2004).
Mouse single-cell qRT-PCR.Fast Blue-positive colonic sensory neurons
were individually harvested from primary cultures of retrogradely la-
beled DRG (TL: T10–L1) by pulled glass pipette. The cells were collected
in PBS, and the pipette tip containing the cell was broken into a tube
containing preamplification mastermix (5 l of CellDirect 2 reaction
buffer (Invitrogen), 2.5 l of 0.2 primer/probe mix, 0.1 l of
SUPERase-in (Ambion), 1.2 l of TE buffer (Applichem), and 0.2 l of
Superscript III Reverse Transcriptase/Platinum Taq mix (Invitrogen);
briefly centrifuged; frozen immediately; and stored at80°C. Only indi-
vidual Fast Blue-positive neurons free from debris were collected.
Samples of the bath solution were collected in the absence of cells for
no-template control experiments. Preamplification of cDNA was
achieved with the following protocol: 50°C for 30 min, 95°C for 2 min,
then 21 cycles of 95°C for 15 s and 60°C for 4 min). The cDNA product
was diluted 1:5 in TE buffer and TaqMan quantitative PCR assays run for
each gene of interest (TaqMan Assay ID: SCN11A, Mm00449367_m1;
P2Y1, Mm02619947_s1; P2Y2, Mm02619978_s1; P2Y4, Mm0044
5136_s1; GAPDH, Mm99999915_g1; Applied Biosystems) with the fol-
Table 1. Details of patients fromwhich human tissue was used in the present studies
Patient Disease Tissue Operation Age (years) Sex
1 Cancer Descending colon Anterior resection 52 M
2 Cancer Descending colon Laparoscopic anterior resection 50 F
3 Cancer Descending colon Anterior resection 76 M
4 Cancer Descending colon Anterior resection 65 F
5 Cancer Descending colon Anterior resection 64 M
6 Cancer Descending colon Subtotal colectomy 47 M
7 Cancer Descending colon Anterior resection 73 M
8 Cancer Descending colon Anterior resection 61 M
9 Cancer Descending colon Anterior resection 57 M
10 Cancer Descending colon Laparoscopic colectomy 54 F
11 Cancer Descending colon Right hemicolectomy 48 F
12 Cancer Ileum Laparoscopic right hemicolectomy 76 M
13 Cancer Appendix Right hemicolectomy 62 F
14 Cancer Appendix Subtotal colectomy 57 M
15 Cancer Appendix Laparoscopic right hemicolectomy 81 F
16 Cancer Appendix Right hemicolectomy 62 M
17 Cancer Appendix Right hemicolectomy 72 M
18 Slow Transit Constipation Descending colon Subtotal colectomy 50 F
19 Stricture Descending colon Sigmoid colectomy 64 F
20 Trauma Ileum Ileotransverse anastomosis and abdominal wall repair 60 M
21a Stricture Appendix Right hemicolectomy 63 F
22 Ulcerative colitis Descending colon Subtotal colectomy 21 M
23 Ulcerative colitis Descending colon Completion proctectomy 37 F
24 Crohn’s disease Ileum Small bowel resection 39 F
25 Crohn’s disease Ileum Right hemicolectomy 30 F
26 Crohn’s disease Ileum Right hemicolectomy 41 F
27 Crohn’s disease Ileum Right hemicolectomy 21 M
28b Crohn’s disease Appendix Right hemicolectomy 16 M
Tissue from 28 patients was collected and used in electrophysiological mesenteric nerve recordings. Patients undergoing surgery were characterized by disease process into two groups, noninflamed (consisting of macroscopically normal
tissues collected from bowel cancer, slow transit constipation, stricture and trauma resections) and inflamed (tissues isolated from inflammatory bowel disease resections). F, Female; M, male.
aFor patients 1–21: mean age, 62 years; male/female ratio, 1:0.75.
bFor patients 22–28: mean age, 29 years; male/female ratio, 1:1.33.
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lowing cycling protocol: 50°C for 2 min, 95°C for 10 min, then 40 cycles
of 95°C for 15 s and 60°C for 1 min on a Bio-Rad C1000 Thermal Cycler
and CFX96 Real-Time System. Glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) acted as an internal positive control. Quantitative
assessment of gene expression was determined by quantification cycle
values less than the threshold of 35 being considered as positive. All
single-cell RT-PCR products expressed GAPDH, while bath control
samples did not.
Extracellular electrophysiology protocols. In whole-nerve recordings,
following a stabilizing period of 30 min, drugs were applied by bath
superfusion of a 20 ml volume, with a minimum 60 min interval main-
tained between the sequential concentrations applied. In the mouse, in-
creasing concentrations of nucleotides, ADP, and UTP (0.1, 1.0, and 3.0
mM; in human, 1 and 10 mM) were applied in separate colonic prepara-
tions. In some human preparations, ADP and UTP (1 and 10 mM) were
applied sequentially with a minimum 60 min interval. In teased-fiber
studies on mesenteric and serosal units, the effect of applying 100 l of
either ADP or UTP (3–10 mM; 2 min) to receptive fields isolated by a
metal ring was also examined on ongoing nerve discharge.
Data analysis. Peak changes in electrophysiological nerve activity in
multiunit experiments were determined by subtracting baseline firing (3
min before drug application) from increases in nerve activity following
nucleotide superfusion. Changes in nerve activity were compared be-
tween Nav1.9
/ and Nav1.9
/ animals using two-way ANOVA with
Bonferroni post hoc test, as appropriate. In teased single-fiber experi-
ments, the average number of spikes per second per stimulus were quan-
tified, and fibers were considered responsive if a maintained 25%
increase in firing discharge above basal levels occurred (Brierley et al.,
2005). Expression data were visualized using R and the ggplot2 package
(Wickham, 2009). Statistical significance was set at p  0.05. Data are
displayed as the mean	 SEM.
Drugs. Stock concentrations of ADP, UTP, and uridine 5-diphosp-
hoglucose disodium salt (UDP; 300mM; water); atropine (10mM; ethanol);
indomethacin (3 mM; DMSO); and nifedipine (10 mM; DMSO) were all
purchased from Sigma-Aldrich and prepared as described. MRS2500 (10
mM; water), pyridoxalphosphate-6-azophenyl-2-disulfonic acid (PPADS;
water), 2
,3
-O-(2,4,6-trinitrophenyl)adenosine-5
-triphosphate tetre(tri-
ethylammonium) salt (TNP-ATP; water), and CGS15943 (DMSO)were all
purchased from Tocris Bioscience. All compounds were diluted to working
concentrations in buffer on the day of experimentation.
Results
UTP and ADP increase visceral sensory neuron excitability
We first assessed the ability for the purine and pyrimidine nucle-
otides UTP (P2Y2 and P2Y4 receptor agonist), UDP (P2Y6 recep-
tor agonist), and ADP (P2Y1, P2Y12 and P2Y13 receptor agonist)
to sensitize the response of colon projecting sensory neurons
(31.4	 1.8 pF; n 53) to repeat 500 ms current injections from
50 to 650 pA applied in 50 pA increments. For example, following
100 pA current injection neurons fired 1.1	 0.2 action potentials
per 500 ms (n 53; Fig. 1A). With increasing current injection,
the frequency of firing also increased with 650 pA injections
evoking 2.7	 0.4 action potentials per 500ms. The application of
UTP or ADP resulted in a significant increase in the total number
of action potentials fired during current injections in 50%or 40%
of cells tested, respectively (p  0.01, n  10, paired t test vs
pre-UTP application; p  0.01, n  6, paired t test vs pre-ADP
application; Fig. 1B,C). After the removal of UTP, the number of
action potentials elicited to current injection returned to baseline
levels (Fig. 1A) in all but one cell tested, by contrast neuronal
excitability remained potentiated for the duration of the wash
period (5 min) following the removal of ADP (cumulative,
55.0 	 12.4 APs; n  6). Preincubation with the selective P2Y1
receptor antagonist MRS2500 inhibited the sensitizing effects of
ADP (10M; p 0.05, n 6, unpaired t test 10MADP vs 10M
ADP plus 10 MMRS2500; Fig. 1C). In addition, the application
of UTP, but not UDP, depolarized the membrane potential
from 59.7 	 0.5 to 53.9 	 2.3 mV (p  0.05, n  6–7,
two-way ANOVA vs control buffer; Fig. 1D), an effect that was
not observed following ADP incubation (pre-ADP,61.7	 1.1
mV; post-ADP,63.4	 3.6mV; n 6). The application ofUDP
failed to increase action potential firing in any cell tested (n 6,
p 0.91, paired t test vs pre-UDP application; Fig. 1B). In addi-
tion, in 4 of 20 cells tested, the application of UTP also evoked
sustained spontaneous activity (an example is shown in Fig. 1E).
Spontaneous activity was observed in 1 of 15 cells following the
application of ADP.
These data show that agonist-driven activation of P2Y recep-
tors can sensitize visceral colonic sensory neurons. To under-
stand how these effects manifest at the level of the sensory nerve
ending, we next investigated the ability of UTP and ADP to di-
rectly excite visceral colonic afferents.
Activation of mouse visceral colonic afferents by UTP and
ADP, but not UDP
Initial studies used multiunit recordings of LSN activity to ob-
serve whole-nerve firing following P2Y receptor activation. This
was later refined to study the discrete effect of applying P2Y ago-
nists to characterized receptive fields of visceral nociceptors. The
application of increasing concentrations of UTP or ADP (100
M, 1 and 3mM) produced robust and concentration-dependent
increases in afferent firing (Fig. 2A–D), with themagnitude of the
response to ADP significantly greater than that to UTP (p 
0.0001, n 6, two-way ANOVA; Fig. 2E). In agreement with our
patch-clamp observations, the application of UDP (1 and 3 mM)
had no effect on colonic afferent fiber activity (Fig. 2G).
To further investigate the contribution of P2Y receptors to
purinergic signaling by ATP, we next sought to determine the
residual afferent response to ATP following pretreatment with
broad-spectrum and selective P2X receptor or P1 (adenosine)
receptor antagonists as an indication of the degree of P2Y recep-
tor activation by ATP. Repeat application of ATP (3 mM) evoked
stable, reproducible whole-nerve responses. Pretreatment with
the P2X antagonist PPADS (30 M), the selective P2X2/3 antago-
nist TNP-ATP (10 M), or the pan-P1 (adenosine) receptor an-
tagonist CGS15943 (3 M) resulted in a reduction of 25% in
afferent response to ATP (p  0.05, paired t test; Fig. 2F), con-
firming not only that P2X receptors are involved, but also indi-
cating that a substantial proportion of the response to exogenous
application of ATP is likely to be P2Y receptor mediated in our
preparation. Together with the observed increases in afferent ac-
tivity following the application of selective P2Y agonists UTP and
ADP, the data demonstrate that the activation of P2Y receptors
has a profound stimulatory effect on visceral afferent activation.
Our recordings were made from the LSN innervating the distal
colon, which has been shown to be predominantly composed of
visceral nociceptors with endings located on the mesenteric and se-
rosal blood vessels of the colon (Brierley et al., 2004). These nocice-
ptors transduce noxious mechanical and chemical stimuli, and are
thought to contribute significantly to thevisceral painandhypersen-
sitivity associated with many gastrointestinal disorders. To confirm
that P2Y receptor activation stimulates visceral nociceptors within
the LSN, we used teased-fiber recordings to study the effects of P2Y
agonists on defined populations of nociceptors with receptive fields
isolated in the serosa ormesentery of flat sheet preparations.Using a
small chamber to isolate the receptive field, we applied UTP (3–10
mM) or ADP (3–10 mM) directly to nociceptor endings. Both UTP
and ADP stimulated nociceptor activity (Fig. 3A–C). However,
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consistent with the whole-nerve studies, ADP activated a greater
proportion of units tested (80%vs 50%; Fig. 3D). Therewere signif-
icantly greater increases in activitywithADPcomparedwithUTP in
serosal units (p 0.05, n 5–8, unpaired t test; Fig. 3C). By con-
trast, responses to ADP and UTP were comparable in mesenteric
units (ADP, 4 of 10 units responded with a response of 0.59	 0.30
spikes/s;UTP, 6of 12units respondedwith a responseof 0.56	0.30
spikes/s).
Overall, we have found that UTP and ADP directly excite a sig-
nificant subsetof visceralnociceptors, and that, inparitywithwhole-
nerve data, ADP is capable of evoking greater excitation than UTP.
As such, this demonstrates that, in addition to the established excit-
atory effect of P2X receptor activation, ATP will also stimulate vis-
ceral nociceptors through the activation of P2Y receptors.
Excitation of human colonic afferents by UTP and ADP
Having established an excitatory effect of P2Y receptor activation
on mouse visceral nociceptors, we next sought to confirm the
translation of this effect from mouse to human visceral nocicep-
tors. To do this, we recordedmesenteric nerve activity in resected
bowel tissues obtained from patients with full written consent
(Table 1, Fig. 4A). As described previously, recordings weremade
from the following three gross tissue regions: ileum, descending
colon, and appendix (Peiris et al., 2011). Studies concentrated on
noninflamed descending colon tissues obtained from patients
undergoing resection for bowel cancer (n  11). These tissues
were taken away from cancer tumors, resection margins, and
lymphatic drainage fields, and were considered noninflamed by
macroscopic assessment. Recordings from descending colon tis-
Figure 1. Increased excitability of mouse colonic sensory neurons by purine and pyrimidine nucleotides. A, Membrane potential of thoracolumbar colonic neurons was observed during
incrementally increasing (50 pA) current injections before and after nucleotide application (10M; 2min). Traces were obtained before (control), during (UTP; 10M), and after (wash) application
of 10M UTP (for clarity, only traces at 100 pA intervals are shown). Inset, Example bright-field image of dissociated dorsal root ganglia neurons overlaid with colonic Fast Blue retrograde labeling.
Scale bar, 10m.B, Cumulative action potentials fired in response to current injections before (n 10), in the presence of (n 10), and after application of 10MUTP (n 6), and in the presence
of 10M UDP (n 6). **p 0.01, paired t test, 10M UTP vs control. C, Cumulative action potentials fired in response to current injections before and in the presence of 10M ADP (n 6), and
in the presence of 10M ADP and 10MMRS2500 (n 6). **p 0.01, paired t test, 10M ADP vs control.D, Membrane potential before and following the application of either control buffer or
nucleotide (2 min; 10M). *p 0.05, n 6–7, two-way ANOVA repeated-measures with Bonferroni post hoc test, 10M UTP vs control. E, Example trace of spontaneous action potential firing
during the application of UTP (10M).
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sues are also likely to be predominantly populated by LSN activity
and are therefore directly translatable to our murine investiga-
tion. In noninflamed descending colon, bath superfusion of UTP
(10mM) led to robust activation of human visceral afferents (Fig.
4B, example trace), with 71%of tissues tested responding with an
increase in afferent firing rates (Fig. 4C). Similarly, ADP (10mM)
also produced an increase in human visceral afferent activity with
responses observed in 86% of preparations tested (Fig. 4C). In
contrast to mouse tissue, where ADP produced greater responses
thanUTP, the visceral afferent response in this defined gut region
and tissue type to UTP was consistently greater in magnitude
than those of ADP (p  0.05, unpaired t test; Fig. 4C). Baseline
firing rates were comparable between preparations tested with
UTP or ADP. Having established the ability of ADP and UTP to
activate human visceral afferents in the descending colon, we
extended this observation by including tissues obtained from
other gut regions (including ileum, appendix, and descending
colon) and from resections necessitated by other noninflamma-
tory disease processes (including stricture, slow transit constipa-
tion, and trauma). The application of UTP and ADP (1 and 10
mM) in these tissues led to concentration-dependent increases in
visceral afferent activity in71%and73%of tissues testedwith10mM
UTP and 10mMADP, respectively (Fig. 4D; Table 2). Furthermore,
themagnitude of the UTP responses was greater than that observed
for ADP in these tissues (p 0.05, unpaired t test; Fig. 4D). Com-
parisonof baseline firing rates betweendifferent regions of respond-
Figure 2. Effect of increasing concentrations of ADP andUTP on colonic splanchnic nerve activity inmouse.A,B, Example neurogramand rate histogram response to 0.1, 1, and 3mMADP (A) and
UTP (B). Below, in both instances, are expanded traces at baseline and following the addition of 3mM nucleotide, and an example action potential. C,D, Average response profiles to the addition of
increasing concentrations of ADP (C; n 6) and UTP (D; n 6). E, Peak increase in nerve activity above baseline following the addition of increasing concentrations of ADP andUTP. ***p 0.001,
n 6, two-way ANOVAwith Bonferroni post hoc test, ADP vs UTP. F, Reduction in peak activity to the application of 3mM ATP following preincubationwith 30M PPADS (n 3), 10M TNP-ATP
(n 5), and 3M CGS 15943 (n 3). G, Effect of P2Y6 agonist UDP on colonic splanchnic nerve activity in mouse, the peak increase in nerve activity above baseline in response to the addition of
1 and 3 mM UDP (n 3) compared with 3 mM ADP and UTP (both n 6, *p 0.05, unpaired t test vs 3 mM UDP). No direct excitation by UDP was observed in any preparation.
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ingnoninflamed tissues showedno significantdifference [e.g., ileum
(0.05 spikes/s; n 1), descending colon (2.50	 0.80 spikes/s; n
11), and appendix (5.79	 5.00 spikes/s; n 4; p 0.31, unpaired t
test, descending colon vs appendix], suggesting that the nerves re-
corded fromwere consistent in ectopic background activity and the
number of nerve fibers regardless of origin along the gastrointestinal
tract; however, this does not exclude that regional pharmacology
may exist.
Figure3. Excitationof isolatedmechanoreceptive fields inmouse colonbypurine andpyrimidinenucleotides.A,B, Example colonic nerve activity to ring applicationofADP (A) andUTP (B; 2min;
10mM) over receptive fields located in the serosa.Mechanically sensitive afferents are shownby response to von Frey hair probe (2 g) before application of nucleotide. Inset, The average spike shape
of the serosal afferents responsive to ADP and UTP. Top trace shows spike rate histogram,middle trace shows serosal afferent activity, and bottom trace shows raw neurogram data. C, Response to
nucleotide ring application in serosal receptive fields. *p 0.05, n 5–8, unpaired t test, UTP vs ADP.D, Proportions of responsive vs nonresponsive serosal units following the application of ADP
and UTP.
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In a limited number of experiments, tissues were collected
from IBD patients to confirm that visceral afferents present in
chronically inflamed tissues remained sensitive to purine and
pyrimidine nucleotides (Table 1). Of those tissues tested, 83%
(five of six tissues) responded to the application of 10 mMADP
with an increase in visceral afferent firing (1.62	 0.53 spikes/
s), while superfusion of 10 mM UTP led to increased visceral
afferent activity (3.30 	 0.97 spikes/s) in 50% of IBD tissues
(three of six tissues) tested (Table 2). The heterogeneity of gut
regions investigated (descending colon, n  2; ileum, n  4;
and appendix, n  1) limit the conclusions that can be drawn
on the relative effects of nucleotide agonists and the sensitivity
of tissue during disease, other than highlighting the ability for
ADP and UTP to excite human visceral afferents during
chronic inflammatory disease.
Human bowel tissues were also routinely and systematically
probed byVFH to identifymechanically sensitive receptive fields.
Once identified, these were characterized by location and re-
sponse toVFHprobe and circumferential stretch in a comparable
way to teased-fiber recordings of the LSN from the distal colon of
mouse. In human bowel tissues, mechanically sensitive receptive
fields were identified in relative low frequency (4 units of 30
recordings from 28 patients), restricting our ability to compre-
hensively characterize the exact afferent subtypes responsive to
purine and pyrimidine nucleotides in human tissues. Four units
were identified that were responsive to VFH probe of the mesen-
Figure4. Effect of purineandpyrimidinenucleotidesonhumanmesenteric nerveactivity fromresectedbowel tissues.A, Example imageof ileumpinned serosaupward in the recording chamber.
Themesenteric nervewithin themesenteric fan is located at the top of the image. Thewhite arrow highlights the glass suction electrode recordingmesenteric afferent activity from themesenteric
nerve.B, Example ratehistogramofnerveactivity following theadditionof 1mMUTP. Expanded tracesofnerveactivity atbaseline (i) andafter applicationofUTP (ii).C, Peak firing ratesoverbaseline
following the application of 10 mM ADP and UTP to noninflamed descending colon tissues isolated from bowel cancer resections only. *p 0.05, n 5–6, unpaired t test. Right, Proportions of
responsive vs nonresponsive noninflamed descending colon tissue preparations. D, Peak firing rates over baseline following the application of 1 and 10 mM ADP and UTP to tissues (including
descending colon, ileum, and appendix) isolated from noninflammatory pathologies (bowel cancer, slow transit constipation, trauma, and stricture). *p 0.05, n 5–11, unpaired t test. Right,
Proportions of responsive vs nonresponsive noninflamed tissue preparations. E, Example of a human mechanically sensitive mesenteric afferent responding to von Frey hair probe (2 g) and
application of ADP (30mM). F, Example of a humanmechanically sensitive serosal afferent (small-amplitude) that was responsive to von Frey hair probe (2 g) but was unresponsive to UTP (10mM).
However, the application of UTP recruited a mechanically insensitive afferent (large-amplitude). Insets, Average spike shapes of serosal and mesenteric afferents and the recruited mechanically
insensitive afferent. The top traces show the spike rate, and the bottom traces show raw neurogram data.
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tery or colon wall, but not to circumferential stretch or mucosal
stroking, a pattern of mechanosensitivity that likely is represen-
tative of sensory afferents associated with the intermural and
mesenteric vasculature, in contrast to the mucosa or intramus-
cular myenteric plexi (Brookes et al., 2013). Based on these
mechanosensitive properties and the location of the receptive
field, one unit was classified asmesenteric, and responded to both
ADPandUTP (for the response toADP, see Fig. 4E). The remain-
ing three units were characterized as serosal by their response to
VFH probing of the colon wall and lack of response to tissue
stretch. The application of ADP or UTP had no effect on activity
in any of the threemechanosensitive serosal units; however, in all
recordings previously “silent” units were recruited, and re-
sponded to sequential addition of both ADP and UTP (for an
example, see Fig. 4F). Mechanosensitive receptive fields were
sought for these recruited units by subsequent von Frey hair
probing; however, none were found, suggesting that these units
may represent examples of mechanically insensitive silent affer-
ents. No units fulfilling the criteria formuscular ormucosal units
were identified in the present study. These findings demonstrate
that human visceral afferents, including those with a visceral no-
ciceptor phenotype, can be activated by P2Y receptor agonists.
This suggests that the release of purine and pyrimidine nucleo-
tides, for example during inflammation, could act via P2Y recep-
tors to trigger visceral pain in humans.
Localization of P2Y1, P2Y2 , and P2Y4 receptors in mouse
colonic sensory neurons
Next we confirmed the expression of P2Y receptors in mouse
colonic sensory neurons. We examined the expression of P2Y1,
P2Y2, and P2Y4 receptors in thoracolumbar gut-projecting sen-
sory neurons by single-cell qRT-PCR (Fig. 5). Data from our
patch-clamp experiments have shown that the effects of ADP
weremediated by P2Y1 receptors, while previous studies (Chen et
al., 2010; Yousuf et al., 2011) show that P2Y2 receptors are pre-
dominantly responsible for the activation of sensory nerves by
UTP.We chose to examine expression inDRGs T10 and L1 levels
as these possess the greatest number of sensory neurons project-
ing to the distal colon via the LSN, the nerve in which our elec-
trophysiological data were recorded (Robinson et al., 2004). In
total, 15 single cells per mouse (n  3) were isolated and pro-
cessed for qRT-PCR. Analysis of qRT-PCR products from co-
lonic sensory neurons revealed greater expression of P2Y1
Table 2. Responsiveness of human tissues to P2Y receptor agonist applications split by disease and gut region
Disease
Descending colon Ileum Appendix
Responders Nonresponders Responders Nonresponders Responders Nonresponders
Cancer
ADP 6 1 1 0 2 1
UTP 5 2 1 0 2 0
Stricture
ADP 1 0 0 0 0 1
UTP 1 0 0 0 0 1
Constipation
ADP 1 0 0 0 0 0
UTP 1 0 0 0 0 0
Trauma
ADP 0 0 0 1 0 0
UTP 0 0 0 1 0 0
Ulcerative colitis
ADP 2 0 0 0 0 0
UTP 0 0 0 0 0 0
Crohn’s disease
ADP 0 0 2 1 1 0
UTP 0 0 2 3 1 0
Figure 5. Expression of P2Y receptors and Nav1.9 mRNA transcripts in mouse colon-projecting sensory neurons by single-cell qRT-PCR. A, Proportion of colon-projecting sensory neurons
expressing transcripts for P2Y1, P2Y2, P2Y4, and SCN11A.B, Coexpression analysis of P2Y1, P2Y2, P2Y4, and SCN11A transcripts in colonic sensory neurones. Each segment represents a single cell with
a filled colored block signifying positive expression.
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transcripts (80.0 	 10.2%) compared with P2Y2 (48.9 	 9.7%)
and P2Y4 transcripts (28.9	 15.6%; Fig. 5A).
Coexpression of P2Yreceptors with Nav1.9 in mouse colonic
sensory neurons
The underlying mechanism by which P2Y receptor activation
alters neuronal excitability and hypersensitivity has been attrib-
uted to multiple ion channels expressed by sensory neurons
(Gerevich and Illes, 2004). We have previously shown that
voltage-gated sodium channel Nav1.9 currents are significantly
enhanced by ATP (Baker, 2005), and, consistent with this obser-
vation, colonic afferent responses to ATP are greatly diminished
in Nav1.9
/ mice (Hockley et al., 2014). These data strongly
suggest that the modulation of Nav1.9 is an important mecha-
nism by which P2Y receptor activation stimulates visceral affer-
ent activity. To support this hypothesis, the coexpression of
Nav1.9 with P2Y1, P2Y2, and P2Y4 was examined in single-cell
qRT-PCR products. Overall, 86.7	 3.8% of thoracolumbar co-
lonic sensory neurons expressed Nav1.9 mRNA transcripts,
which was greater than the proportion observed by isotopic in
situ hybridizations from a previous study (50.5	 3.3%; Hockley
et al., 2014), perhaps reflecting the greater sensitivity of the qRT-
PCR technique. Of the P2Y1 transcript-positive colonic neurons
(Fig. 5B), 86% expressed Nav1.9 transcripts, while 100% of P2Y2
transcript-positive neurons and 92% of P2Y4 transcript-positive
neurons also expressed Nav1.9 transcripts. In addition, substan-
tial coexpression of multiple P2Y receptor subtypes was ob-
served, with 20% of colonic neurons coexpressing all three P2Y
receptor transcripts (P2Y1, P2Y2, and P2Y4), and 44% expressing
both P2Y1 and P2Y2 transcripts.
Loss of Nav1.9 significantly reduces afferent sensitivity to
UTP and ADP
Finally, to confirm that Nav1.9 is required for P2Y receptor-
mediated visceral afferent activation, we examined the effect of
UTP or ADP application in whole-nerve recordings of LSN ac-
tivity from Nav1.9
/ and wild-type (Nav1.9
/) mice (Fig. 6).
Responses to bothUTP (p 0.01, two-wayANOVA; Fig. 6E) and
ADP (p 0.0001, two-way ANOVA; Fig. 6F ) were significantly
reduced in tissue from Nav1.9
/ mice, confirming that P2Y
receptor-mediated activation of visceral afferents is stro-
ngly coupled to Nav1.9 channels. These data provide further
evidence in support of Nav1.9 as a regulator of excitability in
visceral afferents to stimuli involved during chronic gastroin-
testinal inflammation.
Discussion
Our data demonstrate that P2Y1, P2Y2, and P2Y4 receptors are
expressed on gut-projecting sensory neurons and that agonist
stimulation of these receptors sensitizes these neurons. We have
shown that the application of UTP and ADP directly stimulate
both mouse and human visceral afferents, and the expression of
Nav1.9 is required for nucleotide activation of colonic afferents.
We show that activation of P2Y receptors is capable of exciting
mouse visceral nociceptors, an effect that translates to human
nociceptors and, therefore, represents an understudied mecha-
nism in the development of visceral pain. As a consequence, P2Y
receptors are likely an important regulator of visceral pain and
hypersensitivity in disease states where purinergic transmission is
enhanced, such as with inflammation and during distension of
the gut.
Purine and pyrimidine nucleotides, ATP and UTP, are re-
leased from tissues into the extracellular space, where their levels
are regulated by active transport and enzymatic hydrolysis (Ra-
levic and Burnstock, 1998; Burnstock, 1999; Lazarowski and
Boucher, 2001). In the gastrointestinal tract, endogenous ATP is
released from the mucosal epithelium during distension, activat-
ing subepithelial afferents through purinoceptors, most notably
P2X3 (Chen et al., 1995; Burnstock, 1999; Shinoda et al., 2009). In
addition to mechanosensory transduction, the release of ATP
from immune cells and following cell damage implicates puriner-
gic signaling in nociception during inflammation, injury, and
infection (North, 2002; Burnstock, 2009). In colitis, the contri-
bution of ATP to mechanosensitive transduction is enhanced
(Wynn et al., 2004). By contrast, the role of UTP in sensory sig-
naling from the colon has not been extensively studied. Here we
show that UTP is capable of sensitizing colonic sensory neurons.
The same is not true of its metabolite and P2Y6 agonist UDP,
which failed to sensitize gut-projecting neurons. Our data are
consistent with studies showing increased action potential firing
in sensory neurons by UTP and excitation of cutaneous afferent
fibers (Molliver et al., 2002; Stucky et al., 2004; Lechner and
Lewin, 2009). Indeed, thoracolumbar sensory neurons that proj-
ect to the bladder via the LSN are sensitized by UTP acting on
P2Y2 receptors (Chen et al., 2010). The present study builds on
these findings, showing that UTP also sensitizes colonic sensory
neurons, and that ADP acting at P2Y1 is sensitizing in these cells.
Further, we demonstrate that nucleotide-dependent changes in
sensory neuron excitability are consistent with increased afferent
firing in visceral nociceptors of both mouse and human tissue.
This suggests that P2Y receptors are a likely mechanism by which
purine and pyrimidine nucleotides mediate visceral pain in hu-
man disease states.
Our findings are supported by indirect reports suggesting that
P2Y receptors contribute to purinergic activation of visceral af-
ferents and the production of visceral pain. Studies using P2X3
knock-out mice and P2X2/3 dual knock-out mice indicate that
P2X2 and P2X3 receptors contribute to transduction of noxious
stimuli, especially during inflammatory hypersensitivity (Cock-
ayne et al., 2005; Rong et al., 2009; Shinoda et al., 2009).However,
in the colon at least, residual responses to ATP in these mice
suggest that afferent firing may be induced by pathways other
than direct activation of P2X receptors (Rong et al., 2009; Shi-
noda et al., 2009). In agreement with this, we observe only partial
reduction in afferent firing in response to ATP following the
inhibition of P2X receptors by the application of selective antag-
onists TNP-ATP and PPADS, with these effects being compara-
ble in magnitude to previous studies in P2X2/3 dual knock-out
mice (Rong et al., 2009). Furthermore, given that adenosine is an
ectonucleotidase breakdown product of ATP/ADP and can di-
rectly excite afferents in its own right, we show that the pan-P1
receptor antagonist CGS15943 only partially inhibits afferent dis-
charge to ATP, which is consistent with previous reports using P1
antagonist 8p-SPT (Kirkup et al., 1998). In light of our findings
that UTP and ADP stimulate visceral afferent activity, these data
collectively support a role for P2Y receptors as a mechanism of
visceral afferent activation alongside P2X receptors, although
complex interactions may be occurring (Mo et al., 2013). Fur-
thermore, this strongly suggests that the excitatory effects of UTP
or ADP cannot be solely explained by either the activation or
facilitation of P2X channels, or by P1 receptors by UTP/ADP or
their metabolites.
Of the eight P2Y receptors, P2Y1, P2Y2, and P2Y6 receptors are
coupled to stimulatory Gq/11-protein signaling cascades and are
expressed in sensory neurons (Gerevich and Illes, 2004). The
application of UDP had no effect on colonic afferent activity,
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suggesting that P2Y6 receptors are not involved in the sensitiza-
tion of colonic neurons. To confirm that the effects of ADP and
UTP on colonic neurons could be mediated by the expression of
P2Y1 and P2Y2 receptors, respectively, we demonstrated the pres-
ence of P2Y1 transcripts and P2Y2 transcripts in 80% and 49% of
colonic neurons, respectively, using qRT-PCR. P2Y4 transcripts
were also observed in a smaller proportion (30%) of colonic neu-
rons. No previous studies have examined the expression of P2Y
receptors in colonic sensory neurons; however, the expression
levels of P2Y2 are similar to those found in thoracolumbar sen-
sory neurons that project to the bladder (Chen et al., 2010). The
proportions of colonic sensory neurons expressing P2Y1 and
P2Y2 were similar to proportions sensitized by the application of
ADPorUTP in teased-fiber afferent studies (80%or 50%, respec-
tively), providing support for the direct activation of visceral af-
ferents by P2Y receptors.
One important consideration is the extensive expression of
P2Y receptors by both enteric neurons and smooth muscle (Gal-
lego et al., 2006; Zizzo et al., 2012), where they are involved in
neuromuscular transmission and control of gastrointestinal mo-
tility. P2Y1 and P2Y6 receptors have been shown to mediate re-
laxation of intestinal smooth muscle, while P2Y2 and P2Y4
receptors are linked to contraction in the small intestine (John-
son andHourani, 1994; Gallego et al., 2006; Zizzo et al., 2012). To
mitigate this possible source of indirect afferent fiber activation, our
preparations were treated with nifedipine to prevent resultant
Figure 6. Effect of the deletion of Nav1.9 on colonic splanchnic nerve activity to purine and pyrimidine nucleotide agonists. A,B, Example rate histogram of nerve activity following addition of 3
mMUTP in Nav1.9
/mice (A) andNav1.9
/mice (B). Below, Expanded traces of nerve activity at baseline and after the application of UTP,with representative action potentials. C,D, Response
profile to the addition of 1mM UTP (C) and 1mM ADP (D) in both Nav1.9
/ and Nav1.9
/mice (n 6 for each group). E, F, Peak increase in nerve activity in Nav1.9
/ and Nav1.9
/mice
following the additionof 0.1, 1, and3mMnucleotide agonists (E, UTP,p0.01,n6eachgroup; andF, ADP,p0.0001,n6eachgroup; two-wayANOVAwithBonferronipost hoc test). **p
0.01, ***p 0.001.
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changes in gut contractility and atropine to inhibit any confounding
cholinergic-mediated responses to enteric purinoceptor activation
(Duarte-Arau´jo et al., 2009).
Significantly, we demonstrate that our observations in the dis-
tal colon of mouse translate to human colonic afferents by using
ex vivo electrophysiological recordings of surgically resected de-
scending colon. Visceral pain is associated with hyperexcitability
and increased firing of colonic sensory neurons to gut distension
and contraction, typically during, or following, an inflammatory
insult (Knowles and Aziz, 2009). Our data suggest that purine
and pyrimidine nucleotides acting at P2Y receptor subtypes can
sensitize human visceral afferents to evoke increased action po-
tential firing. Indeed, the ability for P2Y agonists to excite human
visceral afferents was also observed in chronically inflamed tis-
sues from IBD patients, suggesting that the activation of P2Y
receptor subtypes cannot be discounted as a potential mecha-
nism contributing to the subset of IBD patients in which chronic
visceral pain represents a significant problem (Isgar et al., 1983;
Grover et al., 2009). In contrast tomurine afferents, however, the
magnitude of response to UTP is significantly greater than ADP
in human tissues. As we and others have shown, ADP and UTP
can evoke comparable sensitization of mouse sensory neurons
(Fig. 1; Yousuf et al., 2011), suggesting that any switch in potency
may bemediated by changes in the downstream coupling of P2Y1
and P2Y2 receptors between mouse and human, or by the differ-
ence in binding affinities between species. The functional conse-
quence of this is not clear; however, this effect was observed in
both noninflamed and, to a lesser extent, inflamed bowel tissues,
indicating that the effect is not attributable to specific disease
pathology.
Finally, we sought to examine the importance of the voltage-
gated sodium channel subtype Nav1.9 in the P2Y receptor-
mediated activation of visceral afferents. We have previously
shown that ATP can enhance Nav1.9 currents (Baker, 2005) and
that Nav1.9 enhancement occurs via a G-protein-coupled mech-
anism (Baker et al., 2003), suggesting that Nav1.9 could be a
downstream effector for P2Y receptor-mediated increases in
neuronal excitability.We found that 86%of P2Y1-positive, 100%
of P2Y2-positive, and 92% of P2Y4-positive mouse colonic sen-
sory neurons coexpressed Nav1.9 transcripts, demonstrating that
Nav1.9 is likely to be a significant effector for P2Y receptor-
expressing visceral afferents. Indeed, we observe substantial
reductions in the afferent response to UTP and ADP in
Nav1.9
/mice, which were greatest at the lower concentrations
of the nucleotides examined. The role of Nav1.9 in prolonging
subthreshold depolarizing stimuli and as a threshold channel reg-
ulating neuronal excitability may confer increased sensitivity to
nucleotides in afferents that coexpress Nav1.9 and P2Y receptors.
The observed importance of Nav1.9 in visceral afferent activation
by nucleotides is of great significance in light of recently identi-
fied human Nav1.9 channelopathies associated with multiple
pain disorders (including episodic pain syndrome and painful
neuropathy), providing evidence that Nav1.9-expressing affer-
ents function as nociceptors in humans (Zhang et al., 2013;
Huang et al., 2014; Han et al., 2015).
To conclude, our data demonstrate that P2Y receptors are
expressed in visceral sensory neurons. Activation of P2Y recep-
tors by selective agonists sensitizes visceral neurons and directly
excites both rodent and human colonic nociceptors, indicating
an important role for P2Y receptors in the generation of visceral
pain during gastrointestinal diseases where purinergic signaling
is enhanced.
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